Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Informational only. Not medical advice.INFORMATIONAL PLATFORM ONLY — NOT MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT
Every Certificate of Analysis we've ingested from certified-pep.com, what each tests for, and what's missing. Sourced back to the original COA URLs — no hosting, no editorial.
Issues our data pipeline flagged on this vendor's COAs. Each flag points at a specific COA and the reason it was raised.
COA labeled 20.00mg but archived vendor listing (bpc-157-10-mg @ 2026-05-20) shows 10.00mg — 50% drift
Each row is one peptide. Columns show whether at least one COA from this vendor for that peptide tests for that property. Endotoxin and sterility are usually the gap.
| Peptide | COAs | Avg purity | HPLC | MS/MALDI | NMR | Endotoxin | Sterility | Metals | Microbial |
|---|---|---|---|---|---|---|---|---|---|
| 31 | 5 | 98.50% | — | — |
Most recent batches we've ingested. Each row links to the original COA file as published by the vendor.
| Peptide | Lot | Lab | Purity | Tests | Tested | |
|---|---|---|---|---|---|---|
| MOTS-C | 260331MO103 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| CJC-1295 no DAC/Ipamorelin | 251212CL103 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
How this is built: we discover every COA URL on the vendor's public testing page, fetch the file, run structured extraction, and persist what each COA actually tests for. Vendor copy isn't a signal — only the COAs themselves.
Full methodology →| — |
| 5-Amino-1MQ | 3 | — | — | — | — | — |
| Adipotide | 1 | 99.80% | — | — | — | — |
| AOD-9604 | 1 | — | — | — | — |
| ARA-290 | 1 | — | — | — | — | — |
| BPC-157/TB-500 | 1 | — | — | — | — |
| Cagrilintide | 2 | — | — | — | — | — |
| Cartalax | 1 | — | — | — | — | — |
| CJC-1295 no DAC | 1 | — | — | — | — | — |
| CJC-1295 no DAC/Ipamorelin | 3 | — | — | — | — |
| Crystagen | 1 | 99.20% | — | — | — | — |
| DSIP | 1 | — | — | — | — | — |
| Epithalon | 1 | — | — | — | — | — |
| GHK-Cu | 2 | 99.24% | — | — | — |
| GHRP-2 | 1 | — | — | — | — | — |
| GHRP-6 | 1 | — | — | — | — | — |
| GLOW | 1 | — | — | — | — | — |
| GLP1-8 | 3 | — | — | — | — |
| GLP2-T | 3 | — | — | — | — |
| GLP3-R | 5 | 99.80% | — | — |
| Glutathione | 1 | — | — | — | — |
| HCG | 2 | — | — | — | — |
| IGF-LR3 | 1 | — | — | — | — | — |
| Kisspeptin | 1 | — | — | — | — | — |
| KLOW | 1 | — | — | — | — | — |
| KPV | 2 | — | — | — | — | — |
| LL-37 | 1 | — | — | — | — | — |
| Melanotan II | 1 | — | — | — | — |
| MOTS-C | 3 | — | — | — | — | — |
| NAD+ | 1 | — | — | — | — | — | — | — |
| Orforglipron | 1 | — | — | — | — | — | — | — |
| Oxytocin | 1 | — | — | — | — | — |
| Pancragen | 2 | 99.80% | — | — | — |
| Pinealon | 1 | — | — | — | — |
| Prostamax | 1 | — | — | — | — |
| PT-141 | 1 | — | — | — | — | — |
| Selank | 1 | — | — | — | — | — |
| Semax | 1 | — | — | — | — | — |
| Sermorelin | 2 | — | — | — | — |
| SLU-PP-332 | 3 | — | — | — | — | — | — |
| Snap-8 | 1 | 98.72% | — | — | — | — |
| TB-4/BPC-157 | 5 | — | — | — | — |
| TB-500 | 1 | — | — | — | — |
| Tesamorelin | 1 | — | — | — | — | — |
| Tesofensine | 2 | — | — | — | — | — | — | — |
| Thymosin Alpha-1 | 1 | — | — | — | — |
| Vifon | 1 | — | — | — | — | — |
| Vilon | 1 | 99.40% | — | — | — | — |
| VIP | 1 | 99.40% | — | — | — | — |
| DSIP | DSIP525 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| GLP1-8 | SEM1025 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| NAD+ | 2250910NAD500-2 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| CJC-1295 no DAC/Ipamorelin | CJCIPA5525 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| 31 | SS3150326 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| Oxytocin | 2512170X103 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| 31 | 260326SS303 | Vanguard Laboratory | 98.49% | — | — | View |
| GLOW | 260405GS503 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| ARA-290 | ARA1025 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| GHRP-2 | GHRP21025 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| GLP1-S | 25126SG53 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| LL-37 | 250819LL5 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| Sermorelin | 260307SR103 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| 31 | 260326SS103 | Vanguard Laboratory | 98.51% | — | — | View |
| VIP | VIP101125 | Vanguard Laboratory | 99.40% | LALUSP<71> | — | View |
| Pinealon | 260401PI203 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| Orforglipron | Orfog6101125 | Vanguard Laboratory | — | — | — | View |
| Tesofensine | 10082025 | Vanguard Laboratory | — | — | — | View |
| Sermorelin | 260405R53 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| 5-Amino-1MQ | 5A1MG25 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| AOD-9604 | 251216AD53 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| GLP3-R | 260211RT103 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| Kisspeptin | KIS525 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| HCG | HCG05425 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| Adipotide | ADI101125 | Vanguard Laboratory | 99.80% | LALUSP<71> | — | View |
| TB-4/BPC-157 | 251212WL103 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| Thymosin Alpha-1 | 260413TL103 | Vanguard Laboratory | — | MSLALHM | — | View |
| BPC-157/TB-500 | 260219WL103 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| BPC-157 | — | Vanguard Laboratory | — | — | — | View |
| Cagrilintide | CAG1025 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| Cagrilintide | 260402CG103 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| Cariintide/Semaglutide | 251227CS53 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| Epithalon | EPI500326 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| GHK-Cu | 260303GK1005 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| Glutathione | GLUT2026 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| GLP3-R | Reta40040126 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| GLP2-T | 251228TZ303 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| GLP2-T | 251220TZ603 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| IGF-LR3 | IGFLR325 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| KPV | KPV1025 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| KLOW | KLW51125 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| Melanotan II | 260416ML103 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| PT-141 | PT1025 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| Semax | 260404SX103 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| 31 | 260326SS303 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| TB-500 | 260120TL103 | Vanguard Laboratory | — | MSLALUSP<71>HM | — | View |
| Tesamorelin | TESA1026 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
| Cartalax | 260203CX203 | Vanguard Laboratory | — | LALUSP<71>HM | — | View |
Disclosed Labs